SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as a sharp pullback in semiconductor stocks creates a tug-of-war between institutional profit-taking and retail investors attempting to buy the dip. The community remains divided, with bulls pointing to the structural long-term demand for AI memory while bears are focused on volatility triggered by broader sector rotation and concerns over potential overcapacity in the AI infrastructure market.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group stock is facing significant volatility following reports that Meta plans to monetize its excess AI compute infrastructure, sparking concerns among investors about increased competition and potential oversupply in the sector. While some community members view this as a major structural threat to the company's profitability, others argue it is an overreaction, emphasizing that Nebiuss existing multi-year capacity contracts and robust demand for specialized AI infrastructure provide a strong foundation for long-term growth.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares (SOXL) is experiencing extreme volatility as traders grapple with geopolitical tensions and conflicting signals about the sustainability of the AI infrastructure boom. The community is actively debating whether current price action represents a temporary dip in a long-term growth cycle or the beginning of a larger correction driven by concerns over semiconductor supply and potential valuation bubbles.

ETF Opportunities Trust - Roundhill T-REX 2X Long DRAM Daily Target ETF

T-REX 2X Long DRAM Daily Target ETF

Investors are actively debating the recent launch of the 2x leveraged RAM ETF, which is designed to track DRAM memory sector momentum alongside the underlying DRAM index. While some community members are aggressive in their bullish outlooks tied to the AI-driven memory supercycle, others express caution regarding the high volatility and decay risks inherent in holding a leveraged product tracking an already cyclical semiconductor niche.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently trending as a focal point of institutional fund rebalancing and sector-wide rotation, with the community actively debating whether its recent price action represents a sustainable breakout driven by AI infrastructure demand or an overextended rally fueled by speculative momentum. Investors are closely monitoring its performance relative to other semiconductor leaders while discussing the stock's potential for further gains based on its long-term strategic role in domestic manufacturing.

Jack in the Box, Inc. engages in the provision of developing, operating, and franchising a chain of quick-service and fast-casual restaurants. It operates through the Jack in the Box and Del Taco segments. The Jack in the Box segment offers a selection of distinctive products including classic burgers and other product lines such as Buttery Jack Burgers. The company was founded by Robert Oscar Peterson in 1951 and is headquartered in San Diego, CA.

Jack In The Box, Inc.

Jack in the Box is trending as retail investors rally behind a short squeeze thesis driven by the company's small float, high short interest, and undervalued brand status. Community discussion focuses on comparing its potential for explosive movement to other recent market phenomena, with many investors debating the mechanics of trapped short positions versus long-term business fundamentals.

PepsiCo, Inc. engages in the manufacture, marketing, distribution, and sale of beverages, food, and snacks. It operates through the following business segments: PepsiCo Foods North America (PFNA), PepsiCo Beverages North America (PBNA), International Beverages Franchise (IB Franchise), Europe, Middle East and Africa (EMEA), Latin America Foods (LatAm Foods), and Asia Pacific Foods. The PFNA segment refers to the food businesses in the United States and Canada. The PBNA segment includes beverage businesses in the United States and Canada. The IB Franchise segment involves the international franchise beverage businesses, as well as the SodaStream business. The EMEA segment pertains to food businesses and beverage businesses with company-owned bottlers in Europe, the Middle East, and Africa. The LatAm Foods segment consists of food businesses in Latin America. The Asia Pacific Foods segment is associated in food businesses in Asia Pacific, including China, Australia and New Zealand, as well as India. The company was founded by Donald M. Kendall, Sr. and Herman W. Lay in 1965 and is headquartered in Purchase, NY.

PepsiCo Inc

PepsiCo is trending as investors weigh potential defensive dividend appeal against recent volume challenges in the beverage segment. Community discussions remain polarized, with participants actively debating the stock's long-term valuation compared to sector peers and monitoring the ongoing impact of managements turnaround and pricing strategies.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is currently a focal point for investors debating its status as a defensive dividend play versus concerns over decelerating same-store sales and shifting consumer spending habits. The community is actively discussing the stock's role as a potential hedge in choppy markets, with technical traders closely monitoring key support levels and valuation gaps compared to peers in the restaurant sector.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors digest the announcement of a late July FDA Advisory Committee meeting for its DMD therapy, deramiocel, with many viewing the public forum as a platform to secure a broad label and validate long-term clinical data. While some market participants are managing volatility associated with the timeline, community sentiment remains highly bullish, focusing on the company's five-year data and the potential for a significant catalyst ahead of the August target decision date.

The TROLL token on the Solana network is a meme coin inspired by internet trolling culture, designed for entertainment and community engagement with no intrinsic value. Built on Solana’s blockchain, it leverages the network’s fast transactions and low fees to appeal to meme enthusiasts. Launched on decentralized exchanges, TROLL aims to foster a fun, community-driven ecosystem through social media, influencer partnerships, and viral marketing, embodying the playful spirit of online trolling.

Troll

Troll (TROLL) is trending as enthusiasts lean into its reputation as an original internet meme with secured IP rights, sparking active discussions about its potential to mirror the performance of other major meme coins. The community remains highly focused on its long-term potential, frequently highlighting it alongside other legacy meme tokens while anticipating significant market growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is MapLight Therapeutics, Inc. (MPLT) Stock a Biotech Opportunity Ahead of the ZEPHYR Trial Readout?

Is MapLight Therapeutics, Inc. (MPLT) Stock a Biotech Opportunity Ahead of the ZEPHYR Trial Readout...

MapLight Therapeutics Autism Drug Shows Mixed Potential In Adolescents

MapLight's ML-004 misses its main autism study goal but showed notable irritability improvements in adolescents.read more...

Maplight Therapeutics (NASDAQ:MPLT) Stock Rating Upgraded by HC Wainwright

HC Wainwright raised shares of Maplight Therapeutics to a "strong-buy" rating in a research report on Monday...

Maplight Therapeutics (NASDAQ:MPLT) Shares Down 5.5% - Here's What Happened

Maplight Therapeutics (NASDAQ:MPLT) Shares Down 5.5% - Here's What Happened...

Jonathan Gillis Sells 51,900 Shares of Maplight Therapeutics (NASDAQ:MPLT) Stock

Maplight Therapeutics, Inc. (NASDAQ:MPLT - Get Free Report) insider Jonathan Gillis sold 51,900 shares of Maplight Therapeutics stock in a transaction on Monday, April 27th. The stock was sold at an...

Anatol Kreitzer Sells 45,422 Shares of Maplight Therapeutics (NASDAQ:MPLT) Stock

Maplight Therapeutics, Inc. (NASDAQ:MPLT - Get Free Report) insider Anatol Kreitzer sold 45,422 shares of the company's stock in a transaction that occurred on Monday, April 27th. The stock was sold...

Insider Selling: Maplight Therapeutics (NASDAQ:MPLT) Insider Sells 17,935 Shares of Stock

Maplight Therapeutics, Inc. (NASDAQ:MPLT - Get Free Report) insider Jonathan Gillis sold 17,935 shares of the company's stock in a transaction dated Tuesday, April 28th. The shares were sold at an...

Maplight Therapeutics (NASDAQ:MPLT) Hits New 52-Week High - What's Next?

Maplight Therapeutics (NASDAQ:MPLT) Reaches New 52-Week High - Should You Buy...

Maplight Therapeutics (NASDAQ:MPLT) Stock Price Up 12.8% - Still a Buy?

Maplight Therapeutics (NASDAQ:MPLT) Stock Price Up 12.8% - Here's Why...

Maplight Therapeutics (NASDAQ:MPLT) Shares Gap Down   - Here's Why

Maplight Therapeutics (NASDAQ:MPLT) Shares Gap Down - Here's Why...

MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for brain disorders. It develops the ML-007-MA product for treatment of schizophrenia and ADP. Its platforms include Optogenetics, Transcriptnomics, and STARmap. The company was founded by Christopher A. Kroeger, Karl Deisseroth, Robert Malenka, and Karoly Nikolich in November 2018 and is headquartered in Redwood City, CA.

MapLight Therapeutics Inc.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$36.08
Prev Close	$35.84
Open	$35.48
Dividend Yield	0.00%
50-Day Moving Average	$29.66
Beta	2.03
Avg. Volume	461,800.85
PE Ratio	-7.99

52-Week High	$37.03
52-Week Low	$12.24
Market Capitalization	$1.53B
EPS (Annual)	-$3.66
Price to Book	4.08
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

MPLTMapLight Therapeutics Inc.

Latest MPLT News